Hu Yu | Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
スポンサーリンク
概要
- HU Yuの詳細を見る
- 同名の論文著者
- Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tecの論文著者
関連著者
-
Sun Chun-yan
Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
-
He Jing
Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
-
HU Yu
Institute of Computing Technology, Chinese Academy of Sciences
-
Hu Yu
Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
-
GUO Tao
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and
-
CHU Zhang-bo
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and
-
Guo Tao
Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
-
Chu Zhang-bo
Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
-
Hu Yu
Institute Of Biomedical Engineering Central South University
-
ZHANG Lu
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and
-
LI Jiang
Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Scienc
-
HUANG Jing
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and
-
Zhang Lu
Institute Of Hematology Union Hospital Tongji Medical College Huazhong University Of Science And Tec
-
Zhang Lu
Institute Of Entomology Shenyang Normal University
-
Li Jiang
Department Of General Surgery Union Hospital Tongji Medical College Huazhong University Of Science A
著作論文
- Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu
- Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylate